# Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas

> **NCT06332196** · NA · UNKNOWN · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 50 (estimated)

## Conditions studied

- Immune Deficiency

## Interventions

- **OTHER:** Analysis of biological sample and clinical data

## Key facts

- **NCT ID:** NCT06332196
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-18
- **Primary completion:** 2025-06-18
- **Final completion:** 2025-10-18
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06332196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06332196, "Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06332196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*